Many of us can easily pinpoint the artificial intelligence (AI) investments in our portfolios. Maybe you've bought shares of AI company stocks or invested in ETFs focused on AI, technology, or ...
Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the former's historical data "to create state-of-the-art, exclusive models for ...
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
Boltz has raised $28 million in fresh funding while entering a strategic partnership with Pfizer that underscores the accelerating push by major drugmakers to embed artificial intelligence deeper into ...